Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.32 |
| ▸ | GLP1R | P43220 | 5/20 | 0.32 |
| ▸ | SLC9A3 | P48764 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7006602 | 1.00 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL13040233 | 1.00 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL19544555 | 0.97 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL21440855 | 0.97 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL21440826 | 0.97 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL12118184 | 0.97 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL12641023 | 0.97 | MEN1 (0.41) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL15942666 | 0.93 | CES2 (0.40) | MEN1KMT2ACES2FAAHTSHR | |
| SCHEMBL21242896 | 0.92 | CES2 (0.42) | MEN1KMT2ACES2SMN1; SMN2FAAH | |
| SCHEMBL21242622 | 0.92 | CES2 (0.42) | MEN1KMT2ACES2SMN1; SMN2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240029409-A1 | TISSUE STAINING AND SEQUENTIAL IMAGING OF BIOLOGICAL SAMPLES FOR DEEP LEARNING IMAGE ANALYSIS AND VIRTUAL STAINING | NEWTRON GROUP SA (CH) | 2024-01-25 | — | — | US | disclosed |
| US-20240029409-A1 | TISSUE STAINING AND SEQUENTIAL IMAGING OF BIOLOGICAL SAMPLES FOR DEEP LEARNING IMAGE ANALYSIS AND VIRTUAL STAINING | NEWTRON GROUP SA (CH) | 2024-01-25 | — | — | US | disclosed |
| US-20230368504-A1 | SYNTHETIC GENERATION OF IMMUNOHISTOCHEMICAL SPECIAL STAINS | AGILENT TECHNOLOGIES, INC. | 2023-11-16 | — | — | US | disclosed |
| US-20230368504-A1 | SYNTHETIC GENERATION OF IMMUNOHISTOCHEMICAL SPECIAL STAINS | AGILENT TECHNOLOGIES, INC. | 2023-11-16 | — | — | US | disclosed |
| WO-2023159170-A1 | SYNTHETIC GENERATION OF IMMUNOHISTOCHEMICAL SPECIAL STAINS | AGILENT TECHNOLOGIES, INC. (US) | 2023-08-24 | — | — | WO | disclosed |
| US-10030065-B2 | MHC multimers, methods for their generation, labeling and use | DAKO DENMARK A/S (DK) | 2018-07-24 | — | — | US | disclosed |
| US-9598720-B2 | Monomeric and polymeric linkers useful for conjugating biological molecules and other substances | DAKO DENMARK A/S (DK) | 2017-03-21 | — | — | US | disclosed |
| US-20160213742-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2016-07-28 | — | — | US | disclosed |
| US-20140080145-A1 | Monomeric and Polymeric Linkers Useful For Conjugating Biological Molecules and Other Substances | DAKO DENMARK A/S (DK) | 2014-03-20 | — | — | US | disclosed |
| US-8546309-B2 | Monomeric and polymeric linkers useful for conjugating biological molecules and other substances | DAKO DENMARK A/S (DK) | 2013-10-01 | — | — | US | disclosed |
| US-20100292133-A1 | TRUNCATED GLP-1 DERIVATIES AND THEIR THERAPEUTICAL USE | NOVO NORDISK A/S (DK) | 2010-11-18 | — | — | US | disclosed |
| US-20100261637-A1 | PEPTIDES DERIVATIZED WITH A-B-C-D- AND THEIR THERAPEUTICAL USE | NOVO NORDISK A/S (DK) | 2010-10-14 | — | — | US | disclosed |
| US-20100168390-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | DAKO DENMARK A/S (DK) | 2010-07-01 | — | — | US | disclosed |
| US-20100120054-A1 | MONOMERIC AND POLYMERIC LINKERS USEFUL FOR CONJUGATING BIOLOGICAL MOLECULES AND OTHER SUBSTANCES | DAKO DENMARK APS (DK) | 2010-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100168390-A1 | MHC MULTIMERS, METHODS FOR THEIR GENERATION, LABELING AND USE | MICA, CD74, HLA-DRB1 | MEN1 2144/4885KMT2A 1233/4885CES2 4535/4885 |
| US-20140080145-A1 | Monomeric and Polymeric Linkers Useful For Conjugating Biological Molecules and Other Substances | PCNA, DCLRE1A, TK1 | MEN1 784/4885KMT2A 2158/4885CES2 1929/4885 |
| US-20100292133-A1 | TRUNCATED GLP-1 DERIVATIES AND THEIR THERAPEUTICAL USE | GLP1R, GIPR, IAPP | MEN1 293/4885KMT2A 826/4885CES2 4822/4885 |
| US-20160213742-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | FPR1, FPR3, FPR2 | MEN1 3710/4885KMT2A 4678/4885CES2 2908/4885 |
| US-10030065-B2 | MHC multimers, methods for their generation, labeling and use | MICA, CD74, HLA-DRB1 | MEN1 3885/4885KMT2A 2448/4885CES2 4881/4885 |
| US-20100261637-A1 | PEPTIDES DERIVATIZED WITH A-B-C-D- AND THEIR THERAPEUTICAL USE | GLP1R, IAPP, GIPR | MEN1 2181/4885KMT2A 4304/4885CES2 3417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.